Navigation Links
Creabilis Appoints Catherine Moukheibir to its Board of Directors
Date:2/28/2013

LUXEMBOURG, February 28, 2013 /PRNewswire/ --

Creabilis SA, a late clinical stage European biotechnology company specialising in the development of treatments in dermatology, inflammation and pain, today announces that it has appointed Catherine Moukheibir to its Board of Directors.

Catherine has gained a wealth of experience in the pharmaceutical industry and finance in career spanning more than 30 years. She is currently Senior Advisor, Finance and Member of the Executive Committee at Innate Pharma, where she was responsible for a key licensing deal between the Company and Bristol-Myers Squibb. Prior to joining Innate Pharma, Catherine was Chief Financial Officer at Movetis, where she played a major role in the Company's IPO on Euronext Brussels and subsequent acquisition by Shire. Prior to joining Movetis, Catherine held a number of senior roles in investment banking including roles at Morgan Stanley and Salomon Smith Barney .

Catherine has held a number of other non-executive positions, including OctoPlus NV and is a partner at STJ Advisors in London. She has an MA and MBA from Yale University, USA.  

Catherine Moukheibir, commenting on her appointment, said: "I'm delighted to join the Creabilis board. The company has matured and now enters an important phase in its ambition to bring advanced science to dermatology, in particular through CT327, in the treatment of chronic pruritus. I look forward to working with the experienced Creabilis team to deliver value from CT327 and other products in its pipeline."

Dr Eliot Forster CEO of Creabilis said: "It is a pleasure to welcome Catherine to our Board of Directors. Her international financial background and successful transaction experience will significantly benefit the company as we seek to maximise the value of our lead product, CT327, in the treatment of chronic pr
'/>"/>

SOURCE Creabilis SA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
2. Verenium Appoints Holger Liepmann To Its Board Of Directors
3. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
4. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
5. Avantium Appoints Jonathan Wolfson to its Supervisory Board
6. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
7. PCI Appoints Jose Solorio-Ruiz, MBA, Manager of West Coast Operations
8. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
9. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
10. uniQure Appoints Philip Astley-Sparke President US
11. HealthEconomics.Com Appoints New Director of Information Technology and Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)...   Cypher Genomics, Inc., the leading genome ... SQNM ), the leading molecular diagnostics company, today ... prenatal tests (NIPT). Through this agreement, Sequenom will ... advance analysis of clinically-relevant fetal sub-chromosomal variants detected ...
(Date:12/25/2014)... 2014 The report “Service Quality Management ... & Provider Type - Global Advancements, Worldwide Forecasts & ... in-depth analysis and forecasting of revenues. , Browse ... pages and in-depth TOC on “Service Quality Management (SQM) ...
(Date:12/24/2014)... Wash. , Dec. 24, 2014   BioLife Solutions , ... and marketer of proprietary clinical grade hypothermic storage ... shipping products for cells and tissues  ("BioLife" or the ... Meeting of Stockholders on May 4, 2015 (the "Annual Meeting"). ...
(Date:12/24/2014)... MA (PRWEB) December 23, 2014 ... is designed to introduce cutting edge communication technology, ... of platform upgrades. This webinar series demonstrates online ... quest to leverage web conferencing’s most innovative and ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3
... ... 20 Years of Experience to Biochemical Innovator, , ... Houston, TX (PRWEB) February 2, 2010 ... microbiology innovations that produce green chemicals, today announced the appointment of Daniel J. ...
... , EXTON, Pa. , ... Board: FCSC), a biotechnology company focused on the development ... applications, announced today that David Pernock , Chairman ... Executive Officer (CEO), effective immediately. Pernock most recently served ...
... , , ... February 2 Elbit Imaging,(NASDAQ: EMITF ) ("Elbit ... medical holdings (InSightec - 60%, and Gamida,Cell - 28%; both on ... offer shares of such subsidiary in a public offering on the,Tel ...
Cached Biology Technology:Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development 2Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development 3Fibrocell Science, Inc. Names David Pernock Chief Executive Officer 2Fibrocell Science, Inc. Names David Pernock Chief Executive Officer 3Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 2Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 3Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 4Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 5
(Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., the leading ... that pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred years ago, ... a meeting place for peoples from different continents. This study ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. One major ... multimodal biometric systems. Multimodal biometric systems utilize more than ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Dr. Ann F. Jacobson, associate professor in Kent States ... initially choose to postpone but ultimately undergo total knee ... education before and after the procedure. ... post operative experiences with total knee replacement surgery, says ...
... 13, 2008.-Unlike most scientific and technological advances, which tend ... finds itself the center of public debate and regulatory ... many of its applications. , In this second ... first was in 2003), the sample has been enlarged ...
... . , A scientific group of the Universities of ... have deciphered for the first time fruit genomic sequence, in this ... issue of the prestigious journal Nature . One of the ... of the Department of Genetics of the ...
Cached Biology News:Research examines factors in delaying or declining total knee replacement surgery 2BBVA Foundation international study on attitudes to stem cell research 2BBVA Foundation international study on attitudes to stem cell research 3BBVA Foundation international study on attitudes to stem cell research 4BBVA Foundation international study on attitudes to stem cell research 5BBVA Foundation international study on attitudes to stem cell research 6Scientists decipher fruit tree genome for the first time 2Scientists decipher fruit tree genome for the first time 3
... microarrays are custom designed to meet your ... available: 8,455 features per array (2 arrays/1" ... per array (1 array/slide). Features ... - This extended length delivers higher ...
... designed for pathway studies, protein-protein interaction ... Studies built on the flexible and ... These microarrays are available as part ... Service. Custom Probe Content ...
... normal Mega Western Protein Array was developed ... Western Protein Arrays are manufactured using high ... sources. A protein sample from each of ... a Protein molecular weight marker on a ...
... 2D Multi-User Applications Package Superior Protein ... Range: The ProXPRESS 2D Proteomic Imaging System ... both proteomic and general life science research ... the use of all dyes in the ...
Biology Products: